Moussa E M, Kotarek J, Blum J S, Marszal E, Topp E M
Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, 47906, West Lafayette, Indiana, USA.
Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Pharm Res. 2016 Jul;33(7):1736-51. doi: 10.1007/s11095-016-1914-4. Epub 2016 Apr 1.
To investigate in vitro the innate immune response to accelerated stress-induced aggregates of intravenous immunoglobulin (IGIV) using a well-defined human cell-line model, and to correlate the innate response to physical properties of the aggregates.
IGIV aggregates were prepared by applying various accelerated stress methods, and particle size, count and structure were characterized. Immune cell activation as tracked by inflammatory cytokines released in response to aggregates was evaluated in vitro using peripheral blood mononuclear cells (PBMC), primary monocytes and immortalized human monocyte-like cell lines.
IGIV aggregates produced by mechanical stress induced higher cytokine release by PBMC and primary monocytes than aggregates formed by other stresses. Results with the monocytic cell line THP-1 paralleled trends in PBMC and primary monocytes. Effects were dose-dependent, enhanced by complement opsonization, and partially inhibited by blocking toll-like receptors (TLR2 and TLR4) and to a lesser extent by blocking Fc gamma receptors (FcγRs).
Stress-induced IGIV aggregates stimulate a dose-dependent cytokine response in human monocytes and THP-1 cells, mediated in part by TLRs, FcγRs and complement opsonization. THP-1 cells resemble primary monocytes in many respects with regard to tracking the innate response to IgG aggregates. Accordingly, the measurement of inflammatory cytokines released by THP-1 cells provides a readily accessible assay system to screen for the potential innate immunogenicity of IgG aggregates. The results also highlight the role of aggregate structure in interacting with the different receptors mediating innate immunity.
使用明确的人类细胞系模型,在体外研究对加速应激诱导的静脉注射免疫球蛋白(IGIV)聚集体的天然免疫反应,并将天然反应与聚集体的物理性质相关联。
通过应用各种加速应激方法制备IGIV聚集体,并对其粒径、数量和结构进行表征。使用外周血单核细胞(PBMC)、原代单核细胞和永生化人类单核细胞样细胞系在体外评估对聚集体反应时释放的炎性细胞因子所追踪的免疫细胞活化情况。
机械应激产生的IGIV聚集体比其他应激形成的聚集体诱导PBMC和原代单核细胞释放更高水平的细胞因子。单核细胞系THP-1的结果与PBMC和原代单核细胞的趋势一致。效应呈剂量依赖性,补体调理作用可增强其效应,阻断Toll样受体(TLR2和TLR4)可部分抑制该效应,而阻断Fcγ受体(FcγRs)的抑制作用较小。
应激诱导的IGIV聚集体在人类单核细胞和THP-1细胞中刺激剂量依赖性的细胞因子反应,部分由TLRs、FcγRs和补体调理作用介导。在追踪对IgG聚集体的天然反应方面,THP-1细胞在许多方面类似于原代单核细胞。因此,测量THP-1细胞释放的炎性细胞因子提供了一个易于使用的检测系统,以筛选IgG聚集体潜在的天然免疫原性。结果还突出了聚集体结构在与介导天然免疫的不同受体相互作用中的作用。